TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Telix Pharmaceuticals Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 20, 2026
$10.74+0.05 (+0.47%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3M
Shares held, 13F filers
Institutional holders
61
24 new, 1 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
3 buys · 0 sales
Net bought $1.02M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Behrenbruch Christian | 23,329,006 | 6.97% | 13G (passive) | Nov 12, 2024 |
| Kluge Andreas | 22,675,000 | 6.78% | 13G (passive) | Nov 12, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TLX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 561,206 | – | $6.47M | −3,551 | 0.00% |
| Lazard Asset Management LLC | 284,207 | – | $3.28M | −5,710 | 0.00% |
| Portland Investment Counsel Inc. | 266,200 | – | $3.07M | – | 0.86% |
| Private Advisor Group, LLC | 197,250 | – | $2.27M | +22,835 | 0.01% |
| Marshall Wace, Llp | 189,188 | – | $2.18M | New | 0.00% |
| Morgan Stanley | 165,978 | – | $1.91M | +49,538 | 0.00% |
| Integrated Wealth Concepts LLC | 164,397 | – | $1.90M | – | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 150,138 | – | $1.73M | New | 0.05% |
| UBS Group AG | 134,698 | – | $1.55M | +102,398 | 0.00% |
| Blair William & Co/Il | 122,985 | – | $1.42M | New | 0.00% |
| Raiffeisen Bank International AG | 115,000 | – | $1.30M | −15,000 | 0.02% |
| Quadrature Capital Ltd | 102,425 | – | $1.18M | New | 0.01% |
| JPMorgan Chase & Co | 77,538 | – | $876.19K | +20,190 | 0.00% |
| XY Capital Ltd | 71,291 | – | $821.99K | +58,739 | 0.79% |
| XTX Topco Ltd | 68,776 | – | $792.99K | +42,769 | 0.01% |
| Vanguard Personalized Indexing Management, LLC | 58,989 | – | $680.14K | +25,736 | 0.01% |
| NLB Skladi, upravljanje premozenja, d.o.o. | 58,000 | – | $668.74K | New | 0.03% |
| Mariner, LLC | 37,085 | – | $427.59K | −6,361 | 0.00% |
| Capricorn Fund Managers Ltd | 36,100 | – | $416.23K | New | 0.03% |
| Gts Securities LLC | 35,537 | – | $409.74K | New | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | 3M | 24 / 21 | 8 / 1 | 1M | 1M |
| Q1 2026 | 39 | 3M | 10 / 17 | 8 / 11 | 2M | 0M |
| Q4 2025 | 40 | 1M | 17 / 11 | 9 / 4 | 1M | 0M |
| Q3 2025 | 27 | 1M | 13 / 8 | 4 / 7 | 1M | 0M |
| Q2 2025 | 21 | 0M | 16 / 3 | 2 / 1 | 0M | 0M |
| Q1 2025 | 6 | 0M | 5 / 0 | 1 / 0 | 0M | 0M |
| Q4 2024 | 1 | 0M | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of TLX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Strategic Advisers U.S. Total Stock Fund | 434,667 | – | $4.10M | 0.00% | May 31, 2026 |
| ActivePassive International Equity ETF | 8,097 | – | $76.35K | 0.01% | May 31, 2026 |
| River Oak Discovery Fund | 5,000 | – | $49.45K | 0.26% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 4,694 | – | $44.26K | 0.00% | May 31, 2026 |
| Steward Values Enhanced International Fund | 3,943 | – | $39.00K | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Christian Behrenbruch | MD & Group CEO, Director | 20,996,941 | May 6, 2026 |
| Darren Charlton Smith | Group Chief Financial Officer | 13,992 | Sep 14, 2026 |
| David Norman Cade | Group Chief Medical Officer | 373,133 | Apr 1, 2026 |
| Darren Joel Patti | Group Chief Operating Officer | 25,558 | Apr 1, 2026 |
| David N. Gill | Director | – | May 18, 2026 |
| William R. Jellison | Director | – | May 18, 2026 |
| Maria Rivas | Director | – | May 18, 2026 |
| Mark Alexander Nelson | Director | 3,628,750 | Apr 1, 2026 |
| Jann Elizabeth Skinner | Director | 595,000 | Mar 18, 2026 |
| Marie Elizabeth McDonald | Director | 3,719 | Mar 18, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Darren Charlton Smith Group Chief Financial Officer | Sep 7, 2026 | Buy | +2,071 | $9.66 | $20.01K | 13,992 |
| Christian Behrenbruch MD & Group CEO, Director | Apr 29, 2026 | Buy | +33,435 | $14.87 | $497.18K | 20,742,935 |
| Christian Behrenbruch MD & Group CEO, Director | Apr 28, 2026 | Buy | +34,500 | $14.48 | $499.56K | 20,709,500 |
| Darren Charlton Smith Group Chief Financial Officer | Mar 29, 2026 | Option exercise | +1,111 | – | – | 11,921 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.